Ying Chen
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- IL-33, ST2, and ILC Pathways
- Immunotherapy and Immune Responses
-
- Occupational and environmental lung diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
- Immunology 57
- IL-33, ST2, and ILC Pathways 9
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 8
- Psoriasis: Treatment and Pathogenesis 8
-
- TGF-β signaling in diseases 10
- Co-authors
- Jie Chen (23 shared papers)Fangwei Liu (17 shared papers)Dong Weng (17 shared papers)Chao Li (10 shared papers)Frank Mücklich (1 shared paper)Andreas Erbe (1 shared paper)Marc Solioz (1 shared paper)Michael Hans (1 shared paper)
- Journals
- Frontiers in Immunology (8 papers)PLoS ONE (6 papers)Theranostics (3 papers)Scientific Reports (2 papers)Journal of Cellular and Molecular Medicine (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ying Chen
128 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 157
- Immunology 1.1k
- Pulmonary and Respiratory Medicine 936
- Cancer Research 301
- Oncology 464
- Molecular Biology 1.1k
Countries citing papers authored by Ying Chen
This map shows the geographic impact of Ying Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Chen more than expected).
Fields of papers citing papers by Ying Chen
This network shows the impact of papers produced by Ying Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Chen. The network helps show where Ying Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 296 | |
| 2 | 2008 | 173 | |
| 3 | 2017 | 127 | |
| 4 | 2010 | 119 | |
| 5 | 2021 | 117 | |
| 6 | 2011 | 115 | |
| 7 | 2022 | 115 | |
| 8 | 2017 | 108 | |
| 9 | 2019 | 107 | |
| 10 | 2013 | 99 | |
| 11 | 2017 | 83 | |
| 12 | 2012 | 82 | |
| 13 | 2019 | 78 | |
| 14 | 2011 | 72 | |
| 15 | 2004 | 69 | |
| 16 | 2013 | 64 | |
| 17 | 2016 | 59 | |
| 18 | 2004 | 58 | |
| 19 | 2016 | 55 | |
| 20 | 2014 | 54 |
About Ying Chen
Ying Chen is a scholar working on Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 139 papers that have together received 3.9k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23 papers), Occupational and environmental lung diseases (19 papers), TGF-β signaling in diseases (10 papers), Nanoparticles: synthesis and applications (9 papers), IL-33, ST2, and ILC Pathways (9 papers), Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (8 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). The work is most often cited by research in Immunology (1.1k citations), Pulmonary and Respiratory Medicine (936 citations), Cancer Research (301 citations), Oncology (464 citations) and Molecular Biology (1.1k citations). Ying Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jie Chen, Fangwei Liu, Dong Weng, Chao Li, Frank Mücklich, Andreas Erbe, Marc Solioz, Michael Hans, Laiyu Song and Ao Zhang. Their work appears in journals such as Frontiers in Immunology, PLoS ONE, Theranostics, Scientific Reports and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.